29 June 2021 : Case report
A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab
Unusual or unexpected effect of treatment, Adverse events of drug therapy
DOI: 10.12659/AJCR.931702
Am J Case Rep 2021; 22:e931702